USA | Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors Guidance for Industry | | https://www.fda.gov/media/158522/download |
USA | Poison Prevention Packaging Act of 1970 Regulations | | https://www.ecfr.gov/current/title-16/chapter-II/subchapter-E |
USA | § 176.170 Components of paper and paperboard in contact with aqueous and fatty foods. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-176/subpart-B/section-176.170 |
USA | § 176.180 Components of paper and paperboard in contact with dry food. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-176/subpart-B/section-176.180 |
USA | § 175.105 Adhesives. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-175/subpart-B/section-175.105 |
USA | § 175.125 Pressure-sensitive adhesives. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-175/subpart-B/section-175.125 |
USA | Subpart K – Labeling and Packaging Control § 820.120 Device labeling. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820/subpart-K/section-820.120 |
USA | § 820.130 Device packaging. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820/subpart-K/section-820.130 |
USA | PART 821 – MEDICAL DEVICE TRACKING REQUIREMENTS | | https://www.ecfr.gov/current/title-21/part-821 |
USA | PART 860 – MEDICAL DEVICE CLASSIFICATION PROCEDURES | | https://www.ecfr.gov/current/title-21/part-860 |
USA | PART 880 – GENERAL HOSPITAL AND PERSONAL USE DEVICES | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-880 |
USA | PART 201 – LABELING | | https://www.ecfr.gov/current/title-21/part-201 |
USA | § 820.30 Design controls. | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820/subpart-C/section-820.30 |
USA | Subpart C – National Drug Code | NDC | https://www.ecfr.gov/current/title-21/part-207/subpart-C |
USA | Current Good Manufacturing Practice Requirements for Combination Products | | https://www.fda.gov/media/90425/download |
USA | Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use Guidance for Industry | | https://www.fda.gov/media/117883/download |
USA | Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format | | https://www.fda.gov/media/128446/download |
USA | Drug Supply Chain Security Act (DSCSA) | Track and Trace, Serialization | https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa |
USA | Product Identifiers Under the Drug Supply Chain Security Act Questions and Answers | | https://www.fda.gov/media/116304/download |
USA | Classification of Products as Drugs and Devices and Additional Product Classification Issues | | https://www.fda.gov/media/80384/download |
USA | Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products | | https://www.fda.gov/media/76403/download |
USA | Glass Syringes for Delivering Drug and Biological Products: Technical Information to Supplement International Organization for Standardization (ISO) Standard 11040-4 | | https://www.fda.gov/media/85748/download |
USA | Labeling for Human Prescription Drug and Biological Products – Implementing the PLR Content and Format Requirements | | https://www.fda.gov/media/71836/download |
USA | ANDA Submissions — Content and Format Guidance for Industry | | https://www.fda.gov/media/128127/download |
USA | Medical Devices with Sharps Injury Prevention Features – Guidance for Industry and FDA Staff | | https://www.fda.gov/media/71142/download |
USA | Needlestick Safety and Prevention Act | | https://www.govinfo.gov/content/pkg/BILLS-106hr5178eh/pdf/BILLS-106hr5178eh.pdf |
USA | Applying Human Factors and Usability Engineering to Medical Devices | | https://www.fda.gov/media/80481/download |
USA | Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management | | https://www.qualysinnova.com/download/files/MD-Use-Safety.pdf |
USA | Use of Recycled Plastics in Food Packaging (Chemistry Considerations) | | https://www.fda.gov/media/150792/download |
USA | Child-Resistant Packaging Statements in Drug Product Labeling Guidance for Industry | | https://www.fda.gov/media/129881/download |
USA | Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities | | https://www.fda.gov/media/102637/download |
USA | Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies, Federal Facilities, and Certain Other Entities | | https://www.fda.gov/media/102615/download |
USA | Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application | | https://www.fda.gov/media/90986/download |
USA | Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities | | https://www.fda.gov/media/90978/download |
USA | Container Closure Systems for Packaging Human Drugs and Biologics Questions and Answers | | https://www.fda.gov/media/70794/download |
USA | Container Closure Systems for Packaging Human Drugs and Biologics Chemistry, Manufacturing, and Controls Documentation | | https://www.fda.gov/media/70788/download |
USA | CPG Sec. 450.500 Tamper-Resistant Packaging Requirements for Certain Over-the-Counter Human Drug Products | | https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-450500-tamper-resistant-packaging-requirements-certain-over-counter-human-drug-products |
USA | CPG Sec. 450.550 Control and Accountability of Labeling Associated with Tamper-Resistant Packaging of Over-the-Counter Drug Products | | https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-450550-control-and-accountability-labeling-associated-tamper-resistant-packaging-over |
USA | Hydrogen Peroxide-Based Contact Lens Care Products: Consumer Labeling Recommendations – Premarket Notification (510(k)) Submissions | | https://www.fda.gov/media/160909/download |
USA | Labeling of Certain Beers Subject to the Labeling Jurisdiction of the Food and Drug Administration | | https://www.fda.gov/media/90473/download |
USA | Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, and Combination Products under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act | | https://www.fda.gov/media/142474/download |
USA | PART 801—LABELING | | https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-801 |
USA | Guidance on Medical Device Patient Labeling | | https://www.fda.gov/media/71030/download |
USA | User Labeling for Devices that Contain Natural Rubber (21 CFR 801.437); Small Entity Compliance Guide | | https://www.fda.gov/media/71135/download |
USA | A Food Labeling Guide | | https://www.fda.gov/media/81606/download |
USA | Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages | | https://www.fda.gov/media/78317/download |
USA | Labeling OTC Human Drug Products (Small Entity Compliance Guide) | | https://www.fda.gov/media/76481/download |
USA | Labeling OTC Human Drug Products — Questions and Answers | | https://www.fda.gov/media/72441/download |